GLP-1 Price Comparison: Semaglutide vs Tirzepatide Across 12 Providers

Semaglutide and tirzepatide are both GLP-1 medications for weight management, but they're not priced the same — and the gap is wider than most people expect. This head-to-head price comparison breaks down exactly what you'll pay for each, across every provider where we have verified data.

Head-to-Head: Semaglutide vs Tirzepatide Pricing

Across all providers with dual pricing, tirzepatide costs 34% to 77% more than semaglutide. The average premium is roughly 50% — meaning if semaglutide costs you $200/month, expect tirzepatide to run closer to $300.

Why Tirzepatide Costs More

Three factors drive the price gap:

1. Manufacturing complexity. Tirzepatide has a more complex molecular structure (it targets two receptors: GLP-1 and GIP). Compounding pharmacies report higher raw material costs and more complex formulation processes for tirzepatide compared to semaglutide.

2. Supply constraints. Semaglutide has been on the market longer and the compounding supply chain is more established. Tirzepatide compounding is newer, with fewer suppliers and tighter raw material availability.

3. Brand-name pricing sets the ceiling. Zepbound (brand-name tirzepatide) has a higher list price than Wegovy (brand-name semaglutide). Compounded versions price relative to their brand-name equivalents, so the gap carries over.

Is the Price Difference Worth It?

Clinical trial data suggests tirzepatide produces greater average weight loss than semaglutide — approximately 20-25% of body weight versus 15% — due to its dual receptor mechanism. But averages mask enormous individual variation. Some patients respond beautifully to semaglutide and see no additional benefit from tirzepatide. Others plateau on semaglutide and do much better switching.

The cost-effectiveness calculation depends on your individual response:

The 12-Month Cost Difference

Over a full year, the semaglutide-to-tirzepatide cost difference ranges from about $400 to $1,200 depending on your provider. That's meaningful money — and a good reason to start with semaglutide unless your provider has a specific clinical reason to recommend tirzepatide first.